HTL Biotechnology is a fast-growing biotechnology company recognised worldwide for its sustainable development and production of innovative pharmaceutical-grade biopolymers. The company collaborates with leading pharmaceutical and medical device companies, significantly impacting the lives of millions of patients worldwide. Dedicated to unleashing the potential of Hyaluronic Acid and biopolymers, HTL Biotechnology has been developing and perfecting a pharmaceutical-grade biopolymer platform for over 30 years.

Services include:
- Biologics
- Contract Development and Manufacturing (CDMO)
- Custom Biopolymer Synthesis
- Analytical Services

HTL Biotechnology remains committed to advancing biopolymer technology and enhancing patient outcomes through its innovative solutions. For more information, please visit htl-bio.com.